Location: Korea
Date:
Event description: Novotech is honored to participate in the inaugural DIA Korea Annual Meeting 2025, themed “Learn and Work: Accelerating Innovative Pharmaceutical Development and Advancing Regulatory Reliance.” This landmark event brings together regulators and industry leaders to strengthen collaboration across clinical development and regulatory science while exploring healthcare innovations in Korea and the broader Asia region. Join Hyun Kim (Country Managing Director), Lilian Kim (Senior Director Business Development), and Dr. Sanghee Kim (Head of Centralised Monitoring and RBQM) as they share Novotech’s perspective on harmonizing global regulatory standards and addressing the evolving clinical trials landscape. Don’t miss Dr. Sanghee Kim’s presentation under Session 5: Topic: Major Korea environment changes which may impact Korean clinical trial execution Date & Time: April 22, 4:05–4:30 PM Followed by: Panel discussion from 4:30–5:20 PM Discover how Novotech's innovative, biotech-focused CRO model is essential to accelerating the delivery of safe and effective therapies. Schedule a meeting via the form on the page to speak with our experts.